[FILM-Users 00363] COMMERCIAL Fwd: Fw: MSC webcast. Using microfluidics for real-time imaging of in vitro cell models

30 May 2013

      ...forwarded for your information, related to the upcoming demonstration 
in FILM,

Martin

-------- Original Message --------
Subject: 	Fw: MSC webcast. Using microfluidics for real-time imaging of 
in vitro cell models
Date: 	Tue, 28 May 2013 18:48:58 +0200
From: 	<donald.innes@merckgroup.com>
To: 	Martin Spitaler <m.spitaler@imperial.ac.uk>

*Donald Innes*
CellASIC ONIX Specialist – UK & Ireland

Merck Millipore, Bioscience Division
Millipore UK Ltd
*
Mobile: +44 (0)7778 473 754*_
__donald.innes@merckgroup.com_ <mailto:donald.innes@merckgroup.com>_
__www.millipore.com_ 
<http://www.millipore.com/?cid=BIOS-S-ESIG-1052-1302-SP>

Merck Millipore is a division of Merck KGaA, Darmstadt, Germany.

CellASIC™ ONIX Microfluidic Platform 
<http://www.millipore.com/life_sciences/flx4/cellasic_live_cell_imaging?cid=BIOS-S-ESIG-1052-1302-SP> 

Text and link to Mandatory Information (in local language)
Text and link to Mandatory Information (in English)

----- Forwarded by Donald Innes/MIUK/Merck on 28/05/2013 17:45 -----

Original message

Nature Publishing Group continues its long standing tradition of 
providing the means for product manufacturers, service providers, 
publishers and other corporations to reach members of the scientific 
community who have opted-in to receive such messages. Nature Publishing 
Group does not endorse any of the products or services advertised here.
To forward this email to a friend, please _click here_ 
<http://links.ealert.nature.com/servlet/FTFClickServlet?m=41609218&r=NTY2NjA2NTcyOTQS1&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1>.

Custom webcast: sponsor retains sole responsibility for content

*Using microfluidics for real-time imaging of /in vitro/ cell models**

Date: Thursday May 30th 2013**

Time:
8am PDT / 11am EDT
4pm BST / 5pm CEST

Speakers:
Dr Andrew Ball*
EMD Millipore
*
Dr. KC Huang*
Stanford University 	

*_
Register for FREE_* 
<http://links.ealert.nature.com/ctt?kn=4&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS1&b=0&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1>

Cell cultures, by definition, inhabit the unsteady ground between tight, 
reproducible experimental control and the ability to simulate the 
complex and dynamic environments found /in vivo/. This webcast reveals 
how pioneering microfluidic technology enables the precise manipulation 
of physiologically relevant micro-environments, helping researchers 
connect cellular mechanisms with phenotypes and disease states.

Microfluidic cell culture chambers allow crucial parameters such as 
media flow, temperature and gas environment to be automated. This 
enables researchers to recreate the mass transport environment of 
tissues, elicit cell responses to dynamic solution changes and enable 
long-term perfusion culture – a real-time, live cell analysis with 
unprecedented control.

The first speaker, Dr. Andrew Ball, will review a specific workflow 
involving microfluidic chambers used with a fluorescent microscope and 
image analysis software, to provide insights for live cell dynamic 
applications such as host-pathogen interactions, cancer cell autophagy, 
and cell migration in a standardized format.

Then, Dr. KC Huang, will discuss how specific microfluidic techniques 
have allowed him to study damped oscillations of bacterial growth in 
response to osmotic shock. Dr. Huang will describe the advantages of 
real-time, live cell analysis in a microfluidic context.

In this webcast you learn:
• The advantages and challenges of using microfludic cell culture tools 
in cell biology
• Techniques that can be used to develop and quantify/in vitro/ cell 
models for predictive cell analysis.

*_Register for FREE_* 
<http://links.ealert.nature.com/ctt?kn=4&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS1&b=0&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1>*
**_
_**_View our archived webcasts_* 
<http://links.ealert.nature.com/ctt?kn=24&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS1&b=0&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1>*

*
*#MSCwebcasts *

Share:
_Facebook_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=FA>_LinkedIn_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=LI>_Reddit_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=RD>_StumbleUpon_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=SU>_Twitter_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=TW&qstparam=%26text%3D>_Digg_ 
<http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NTIyMTkyS0&j=MTg5NTY0MjUxS0&rt=1&n=DG>

As a registered user of Nature Publishing Group's Web sites, our 
database indicates that you have opted-in to receive third-party emails. 
If you no longer wish to receive third-party emails from Nature 
Publishing Group please _update your online account_ 
<http://links.ealert.nature.com/ctt?kn=15&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS1&b=0&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1>. 

For further information on _technical assistance_ 
<mailto:registration@nature.com>| _print subscriptions_ 
<mailto:subscriptions@nature.com>| _other enquiries_ 
<mailto:feedback@nature.com>.
------------------------------------------------------------------------
Customer Service Dept.
Nature Publishing Group 75 Varick St Fl 9 | New York | NY 10013-1917 | 
USA 
<http://links.ealert.nature.com/ctt?kn=21&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS1&b=0&j=MTg5NTY0MjUxS0&mt=2&rj=MTg5NTIyMTkyS0&rt=1> 

This message and any attachment are confidential and may be privileged 
or otherwise protected from disclosure. If you are not the intended 
recipient, you must not copy this message or attachment or disclose the 
contents to any other person. If you have received this transmission in 
error, please notify the sender immediately and delete the message and 
any attachment from your system. Merck KGaA, Darmstadt, Germany and any 
of its subsidiaries do not accept liability for any omissions or errors 
in this message which may arise as a result of E-Mail-transmission or 
for damages resulting from any unauthorized changes of the content of 
this message and any attachment thereto. Merck KGaA, Darmstadt, Germany 
and any of its subsidiaries do not guarantee that this message is free 
of viruses and does not accept liability for any damages caused by any 
virus transmitted therewith.

Click _http://www.merckgroup.com/disclaimer_to access the German, 
French, Spanish and Portuguese versions of this disclaimer.

Martin Spitaler

tags

participants (1)